Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/16/2014EP2717880A1 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
04/16/2014EP2717879A1 Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions
04/16/2014EP2717878A1 Treatment of respiratory disorders using trpa1 antagonists
04/16/2014EP2717877A1 Organic compounds
04/16/2014EP2717876A1 Methods of inhibiting muscle atrophy
04/16/2014EP2717875A2 Bisacodyl and analogues as drugs for treating cancer
04/16/2014EP2717874A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
04/16/2014EP2717873A1 Pyrazole derivatives
04/16/2014EP2717872A1 Synergistic combination for the treatment of type 2 diabetes mellitus
04/16/2014EP2717871A2 Reduction of microglia-mediated neurotoxicity by kv1.3 inhibition
04/16/2014EP2717870A1 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
04/16/2014EP2717869A2 Methods of treatment using a bcat1 inhibitor
04/16/2014EP2717868A1 Combination comprising umeclidinium and a corticosteroid
04/16/2014EP2717867A1 Dry powder inhaler compositions comprising umeclidinium
04/16/2014EP2717866A2 Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer
04/16/2014EP2717865A2 Methods and compositions for treating brain cancer
04/16/2014EP2717864A1 Biopassivating membrane stabilization by means of nitrocarboxylic acid-containing phospholipids in preparations and coatings
04/16/2014EP2717857A1 Method for the synthesis of porphyrin-phospholipid conjugates
04/16/2014EP2717856A2 Ceramide anionic liposome compositions
04/16/2014EP2717852A1 Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
04/16/2014EP2717721A1 An edible composition
04/16/2014EP2717699A1 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
04/16/2014EP2717698A1 Antihistamines combined with dietary supplements for improved health
04/16/2014EP2717696A1 5-fluorocytosine as a seed treatment
04/16/2014EP2717695A1 Methods for reducing neurodegeneration
04/16/2014EP2717693A1 Skin treatments containing pyrroloquinoline quinine (pqq) esters and methods of preparation and use thereof
04/16/2014EP2717692A1 Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids
04/16/2014EP2717690A1 Ophthalmic compositions
04/16/2014EP2717689A2 Novel sglt inhibitors
04/16/2014EP2717688A1 Uses of histone acetyltransferase activators
04/16/2014CN1964967B Lewis acid mediated synthesis of cyclic esters
04/16/2014CN103733069A Method of screening for chaperonin modulator
04/16/2014CN103732748A Production method for nucleic acid aptamer
04/16/2014CN103732746A Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
04/16/2014CN103732608A A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
04/16/2014CN103732597A Tricyclic heterocyclic compounds and JAK inhibitors
04/16/2014CN103732596A Novel pyrrolo pyrimidine derivatives
04/16/2014CN103732595A Folate conjugates of albumin-binding entities
04/16/2014CN103732594A Tenofovir alafenamide hemifumarate
04/16/2014CN103732593A Quinazoline-2,4-dione derivatives
04/16/2014CN103732592A Insulin-like growth factor-1 receptor inhibitors
04/16/2014CN103732589A Substituted sulfonamides useful as antiapoptotic BCL inhibitors
04/16/2014CN103732588A Spirocyclic molecules as protein kinase inhibitors
04/16/2014CN103732586A Acetyltanshinone IIA (ATA) as anticancer agent
04/16/2014CN103732584A Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
04/16/2014CN103732580A Process for the synthesis of cyclic alkylene ureas
04/16/2014CN103732579A Process for the synthesis of N-substituted cyclic alkylene ureas
04/16/2014CN103732578A Quinolinyl glucagon receptor modulators
04/16/2014CN103732577A New thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments
04/16/2014CN103732265A Anti-adhesion medical material and method for producing same
04/16/2014CN103732258A Oral formulations for promoting cellular purification
04/16/2014CN103732234A Wound healing device and method
04/16/2014CN103732233A Peritoneal dialysis solutions comprising glucose polymers
04/16/2014CN103732232A A composition comprising an antibiotic and a dispersant or an anti -adhesive agent
04/16/2014CN103732231A Prevention and treatment of inflammatory conditions
04/16/2014CN103732230A Pharmaceutical composition, methods for treating and uses thereof
04/16/2014CN103732229A Method for treating cancer by combined use of medicinal agents
04/16/2014CN103732228A Animal ectoparasite-controlling agent and method for preventing or treating infection in animals caused by parasites by using the controlling agent
04/16/2014CN103732227A Pharmaceutical composition containing diamine derivative
04/16/2014CN103732226A mTOR/JAK inhibitor combination therapy
04/16/2014CN103732225A Antimicrobial compositions
04/16/2014CN103732224A Composition for eyelash growth
04/16/2014CN103732223A Medical food for cognitive decline
04/16/2014CN103732222A Modified biotin-binding protein, fusion proteins thereof and applications
04/16/2014CN103732221A Gallium complexes, pharmaceutical compositions and methods of use
04/16/2014CN103732218A Targeted delivery of retinoid compounds to the sebaceous glands
04/16/2014CN103732217A Stabilized topical formulations containing core-shell microcapsules
04/16/2014CN103732209A Use of oligosaccharide compounds for the prevention and treatment of pathological scars
04/16/2014CN103732080A Method for reducing the occurrence of infection in young children
04/16/2014CN103732075A Tobacco chewing gum formulation
04/16/2014CN103732065A Benzofuran compounds for the treatment of hepatitis c virus infections
04/16/2014CN103732064A Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
04/16/2014CN103732062A Methods of treating multiple sclerosis and preserving and/or increasing myelin content
04/16/2014CN103732061A Carbonyl containing compounds for controlling and repelling cimicidae populations
04/16/2014CN103732060A Antimicrobial composition
04/16/2014CN103732059A Nuclear hormone receptor modulators
04/16/2014CN103728294A Applications of bisbenzimidazole bicarbazole compound in specific binding nucleic acid G-quadruplex structure and anti-tumor drug
04/16/2014CN103728262A Combination and method for killing staphylococcus aureus
04/16/2014CN103725791A Egfr inhibitor treatment marker
04/16/2014CN103725650A VEGF (Vascular Endothelial Cell Growth Factor) containing plant oil body gel
04/16/2014CN103725649A Vegetable oil gel containing bFGF
04/16/2014CN103725576A Traditional Chinese medicine liquor and preparation method thereof
04/16/2014CN103725552A Herba Polygalae Japonicae health liquor used for tonsillitis
04/16/2014CN103725548A Bamboo leaf health care wine for toothache
04/16/2014CN103725536A Safflower health wine for myopia
04/16/2014CN103725531A Fruit of Chinese wolfberry health care wine for swelling and pain of eye
04/16/2014CN103725519A Chinese olive health spirit having effect of relieving heatstroke
04/16/2014CN103724447A Extraction and classification method of lentinan
04/16/2014CN103724445A Preparation method and blood sugar lowering function of Grifola frondosa polysaccharide F2
04/16/2014CN103724374A Benfotiamine compound, preparation method and pharmaceutical composition containing benfotiamine compound
04/16/2014CN103724364A Asymmetry oxamide fiber-bridged three-kernel copper complex as well as preparation method and application thereof
04/16/2014CN103724360A Pyridine (or benzene) thiazole compound shown and intermediate, preparation method and application thereof
04/16/2014CN103724359A Amorphous cefotetan acid, method for preparing cefotetan disodium by amorphous cefotetan acid and pharmaceutical composition containing cefotetan disodium
04/16/2014CN103724356A Fullereneporphyrin derivate photosensitizer as well as preparation method and application thereof
04/16/2014CN103724351A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724350A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724349A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724343A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
04/16/2014CN103724342A New antifungal drug compound as well as composition thereof and use
04/16/2014CN103724339A Crystal forms of dihydropyrimidine derivatives
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 7860